ArticlePeerJ2026
Assessment of physicians' awareness and clinical practice regarding gingival enlargement caused by calcium channel blockers.
Article in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Assessment of Cardiologists' Knowledge, Attitudes, and Practices on Calcium Channel Blocker-Induced Gingival Overgrowth.Oral health & preventive dentistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Gingival enlargement is a side effect of calcium channel blockers (CCBs), which are usually used to treat cardiovascular conditions. Physicians have an important role in identifying and managing the disease, but their level of awareness and ability to apply their knowledge in clinical practice remain unclear in Iraq. Objective: This study aims to assess physicians' knowledge of calcium channel blocker (CCB)-induced gingival enlargement and determine whether they apply this knowledge in their clinical practice. Methods: A cross-sectional survey was conducted among 331 physicians working in Iraqi primary healthcare institutions to collect the data for this study. A Google Forms questionnaire was designed, created, and distributed Results: The study analyzed responses to questions regarding awareness and management of gingival enlargement linked with calcium channel blocker (CCB) drugs. Only 58% of physicians reported that CCB use causes gingival enlargement as a side effect. However, fewer responders (33.5%) believed they informed patients about this risk. Furthermore, 57.7% of respondents said they do not regularly refer patients for gingival assessment related to CCB use. When asked about factors affecting the occurrence and severity of gingival enlargement, the majority (88.2%) identified a combination of individual susceptibility, dental hygiene levels, and specific medication as relevant factors for this. Most respondents (73.4%) approved that improving oral hygiene and professional cleanings assist in managing drug-induced gingival enlargement. Conclusion: There is a gap between the knowledge of physicians regarding the role of calcium channel blockers in causing gingival enlargement and their clinical practice. Enhancing medical-dental collaboration and providing targeted education can lead to better management and outcomes for patients experiencing CCB-induced gingival enlargement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.